Midgard Science
M

Minaris

Philadelphia, PA, United States minaris.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Minaris is a cell and gene therapy CDMO and contract testing company serving therapy developers and biologics companies. It supports programs from preclinical development through commercial production with manufacturing, technology transfer, and testing operations in North America, Europe, and Asia.

Services

  • Cell banking

    Provides cGMP cell banking services and generates research, master, and working cell banks for advanced therapy programs.

  • Cell therapy technology transfer

    Provides structured technology transfer for cell therapy programs, including site-to-site and development-to-manufacturing transfers.

  • Cell therapy process development

    Develops and optimizes cell therapy processes for autologous and allogeneic platforms, including closed and automated workflows.

  • Cell therapy analytical development

    Develops analytical test methods for release and in-process control testing of cell therapy products.

  • Cell therapy GMP manufacturing

    Provides clinical and commercial GMP manufacturing for autologous and allogeneic cell therapies.

    CDMO: development & manufacturing

  • Viral vector process development

    Develops upstream, downstream, and formulation processes for viral vectors, including AAV and lentiviral programs.

  • Viral vector GMP manufacturing

    Provides GMP manufacturing for viral vectors across early-phase clinical and commercial supply.

    CDMO: development & manufacturing

  • Plasmid engineering

    Provides plasmid solutions, including SnapFast™ plasmids for vector and cell therapy programs.

11 more services
  • TESSA® technology
  • XOFLX® cell lines
  • Analytical development
  • Assay transfer
  • Biosafety testing
  • Cell line characterization
  • Lot release testing
  • Potency testing
  • Stability testing
  • Viral clearance testing
  • Transmission electron microscopy (TEM)

Capabilities

Assays and studies
  • Cell therapy
  • Analytical development
  • Process development
  • AAV
  • Lentivirus
  • Bioreactors
17 more
  • Stability studies
  • HEK293
  • Antibodies
  • Assay transfer
  • Biosafety testing
  • Cell line characterization
  • Lot release
  • Potency
  • Stability
  • Viral clearance testing
  • TEM
  • In vitro adventitious virus assays
  • Replication competent retrovirus testing
  • 9CFR viral detection assays
  • Titering and viral quantification assays
  • Molecular methods including NGS
  • Sterility testing
Scale and capacity
  • Over 7,500 GMP batches produced
  • 4 commercially experienced sites across 3 continents
  • Up to 200L for development
  • Up to 1,000L
  • Commercial and clinical manufacturing facilities in Germany (Munich), the US (Philadelphia, PA and Allendale, NJ) and Ja
Therapeutic areas
  • Cell and gene therapy
  • Biologics
  • Viral vaccines

Instruments and platforms

  • Transmission Electron Microscopy (TEM)
  • Xuri
  • Prodigy
  • G-Rex
  • Cell factories
  • 3D bioreactors
  • Hyperstacks
  • Single-use bioreactor systems

Modalities and species

Modalities
  • Antibody
  • Viral vector
  • Cell therapy
  • Gene editing
  • Vaccine
  • Plasmid DNA
Species and models
  • HEK293
  • HEK293T

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: cell banking, manufacturing, and TEM services

  • ISO/IEC 17025Self-reported

Details

Type
CRDMO
Address
400 Rouse Boulevard, Philadelphia, PA 19112
Sites
  • Philadelphia, PA, United States
  • Allendale, NJ, United States
  • Munich, Germany
  • Yokohama, Japan
  • Taufkirchen, Germany
  • London, United Kingdom
Serves
North America, Europe, Asia, worldwide

Similar labs